Sirius Xm Hldgs (SIRI) Holder Hussman Strategic Advisors Upped Position; 12 West Capital Management LP Upped Alnylam Pharmaceuticals (ALNY) Position by $43.90 Million

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Logo

12 West Capital Management Lp increased its stake in Alnylam Pharmaceuticals Inc (ALNY) by 179.47% based on its latest 2019Q1 regulatory filing with the SEC. 12 West Capital Management Lp bought 472,000 shares as the company’s stock declined 6.55% . The hedge fund held 735,000 shares of the health care company at the end of 2019Q1, valued at $68.69 million, up from 263,000 at the end of the previous reported quarter. 12 West Capital Management Lp who had been investing in Alnylam Pharmaceuticals Inc for a number of months, seems to be bullish on the $9.37B market cap company. The stock increased 0.79% or $0.65 during the last trading session, reaching $83.34. About 444,539 shares traded. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has declined 19.85% since September 10, 2018 and is downtrending. It has underperformed by 19.85% the S&P500. Some Historical ALNY News: 03/05/2018 – ALNYLAM 1Q LOSS/SHR $1.41; 12/03/2018 – Busy Sanofi takes a pass on one of Alnylam’s rare disease drugs, FDA offers ‘breakthrough’ status for PhIII $SNY $ALNY; 28/03/2018 – #EASL2018 late breakers still embargoed for official press program $CBAY PPARδ Ph2 PBC $NVS FXR Ph2 PBC @NGMBio FGF19 Ph2 PSC $ALNY Givosiran in AIP; 28/03/2018 – Alnylam and Collaborators to Present Clinical Study Results in Acute Hepatic Porphyrias (AHPs) at The 53rd International Liver; 03/05/2018 – ALNYLAM PHARMACEUTICALS INC – IF LUMASIRAN PHASE 3 STUDY POSITIVE, AN NDA SUBMISSION ANTICIPATED IN EARLY 2020; 20/04/2018 – DICERNA PHARMACEUTICALS – SETTLEMENT ALLOWS CO TO ADVANCE ALL KEY, PLANNED PIPELINE PROGRAMS; 14/03/2018 – Alnylam to Report New Clinical Results From the APOLLO Phase 3 Study of Patisiran at the 16th Intl Symposium on Amyloidosis; 21/03/2018 – $REGN $ALNY NASH collaboration; 14/03/2018 – Alnylam to Present More Clinical Data for ALN-TTRsc02, Which Is on Track to Enter Phase 3 Development in Late 2018; 20/04/2018 – Alnylam: Settlement Doesn’t Include Any Admission of Liability or Wrongdoing by Either Co

Hussman Strategic Advisors Inc increased its stake in Sirius Xm Hldgs Inc (SIRI) by 58.48% based on its latest 2019Q1 regulatory filing with the SEC. Hussman Strategic Advisors Inc bought 300,000 shares as the company’s stock rose 6.46% . The institutional investor held 813,000 shares of the broadcasting company at the end of 2019Q1, valued at $4.61 million, up from 513,000 at the end of the previous reported quarter. Hussman Strategic Advisors Inc who had been investing in Sirius Xm Hldgs Inc for a number of months, seems to be bullish on the $27.79 billion market cap company. The stock increased 0.56% or $0.03 during the last trading session, reaching $6.32. About 11.25M shares traded. Sirius XM Holdings Inc. (NASDAQ:SIRI) has declined 10.44% since September 10, 2018 and is downtrending. It has underperformed by 10.44% the S&P500. Some Historical SIRI News: 09/04/2018 – SIRIUS REAL ESTATE LTD -FY LIKE-FOR-LIKE ANNUALISED RENTAL INCOME INCREASED IN EXCESS OF 5%; 11/04/2018 – “Coachella Radio” Channel to Launch Exclusively on SiriusXM in Advance of Coachella Valley Music and Arts Festival; 25/04/2018 – SIRIUS XM 1Q ADJ EBITDA $531.8M, EST. $515.8M; 19/04/2018 – CRB AGREES TO RECONSIDER SIRI’S CURRENT 15.5% RATE: SUSQUEHANA; 25/04/2018 – SIRIUS XM HOLDINGS INC QTRLY AVERAGE SELF-PAY MONTHLY CHURN 1.8 PCT VS. VS 1.8 PCT REPORTED LAST YEAR; 24/05/2018 – S&P AFFIRMS SIRIUS XM RADIO ‘BB’ RATING; OUTLOOK STABLE; 09/05/2018 – Liberty Media Sirius XM 1Q Rev $1.38B; 18/04/2018 – NISSAN NORTHAM & SIRIUSXM EXTEND PACT THROUGH 2023 MODEL YEAR; 29/03/2018 – STRABAG SE STRV.Vl – AWARDED TUNNELLING CONTRACT FOR SIRIUS MINERALS’ NORTH YORKSHIRE POLYHALITE PROJECT; 19/04/2018 – DJ Sirius XM Holdings Inc, Inst Holders, 1Q 2018 (SIRI)

12 West Capital Management Lp, which manages about $1.10B and $1.23 billion US Long portfolio, decreased its stake in Fleetcor Technologies Inc (NYSE:FLT) by 48,470 shares to 482,338 shares, valued at $118.94 million in 2019Q1, according to the filing.

Investors sentiment increased to 1.27 in 2019 Q1. Its up 0.20, from 1.07 in 2018Q4. It improved, as 19 investors sold ALNY shares while 71 reduced holdings. 34 funds opened positions while 80 raised stakes. 93.35 million shares or 4.83% more from 89.04 million shares in 2018Q4 were reported. Fukoku Mutual Life Ins invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Daiwa Group invested 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Rhenman And Prns Asset Mgmt Ab reported 91,550 shares. Bailard Incorporated invested in 3,500 shares. Asset has invested 0.01% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Gulf Financial Bank (Uk) reported 0.03% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Retail Bank Of Nova Scotia accumulated 34,000 shares. Moreover, Cornerstone Advsrs has 0% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Piedmont has 0.02% invested in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Tci Wealth reported 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Strs Ohio holds 0% or 1,067 shares in its portfolio. Westpac Banking Corporation holds 0% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) for 5,689 shares. The New Jersey-based Bessemer Gp has invested 0% in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Deutsche Bankshares Ag stated it has 0.03% of its portfolio in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). Amalgamated Bank reported 20,971 shares.

More notable recent Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) news were published by: Nasdaq.com which released: “Alnylam’s (ALNY) Impressive Pipeline Drives Share Price – Nasdaq” on March 18, 2019, also Streetinsider.com with their article: “Ironwood (IRWD), Alnylam Pharma (ALNY) Enter US GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in AHP – StreetInsider.com” published on August 13, 2019, Nasdaq.com published: “Alnylam (ALNY) Reports Narrower-Than-Expected Loss in Q1 – Nasdaq” on May 02, 2019. More interesting news about Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) were released by: Streetinsider.com and their article: “Alnylam Pharma (ALNY) Presents New Clinical Research Findings at Second European Meeting of ATTR Amyloidosis for Doctors and Patients – StreetInsider.com” published on September 03, 2019 as well as Seekingalpha.com‘s news article titled: “Alnylam Pharmaceuticals Q1 2019 Earnings Preview – Seeking Alpha” with publication date: April 30, 2019.

Investors sentiment increased to 2.25 in Q1 2019. Its up 1.29, from 0.96 in 2018Q4. It increased, as 32 investors sold SIRI shares while 81 reduced holdings. 86 funds opened positions while 168 raised stakes. 899.77 million shares or 25.50% more from 716.95 million shares in 2018Q4 were reported. Commerzbank Aktiengesellschaft Fi holds 0.01% or 194,843 shares in its portfolio. Tiaa Cref Invest Mgmt Lc reported 8.85 million shares stake. Qs Investors Ltd Liability holds 0% or 10,300 shares. Pinebridge Investments LP reported 22,708 shares stake. Nomura invested 0% in Sirius XM Holdings Inc. (NASDAQ:SIRI). Copeland Capital Limited Liability Company stated it has 0.01% in Sirius XM Holdings Inc. (NASDAQ:SIRI). Bruce And Co holds 2.18% in Sirius XM Holdings Inc. (NASDAQ:SIRI) or 1.97M shares. Petrus Tru Lta has 56,435 shares for 0.06% of their portfolio. Loomis Sayles And LP holds 0% or 387,290 shares. Lpl Limited Liability owns 229,615 shares for 0% of their portfolio. Pinnacle Associate Ltd accumulated 61,536 shares. Bryn Mawr Tru invested in 0.01% or 32,520 shares. Amer Asset Mgmt holds 0.05% of its portfolio in Sirius XM Holdings Inc. (NASDAQ:SIRI) for 12,614 shares. Merian (Uk) Ltd holds 0.04% or 696,486 shares in its portfolio. Rhumbline Advisers holds 0.02% in Sirius XM Holdings Inc. (NASDAQ:SIRI) or 2.27 million shares.

More notable recent Sirius XM Holdings Inc. (NASDAQ:SIRI) news were published by: Nasdaq.com which released: “CBS Corporation (CBS) Ex-Dividend Date Scheduled for September 09, 2019 – Nasdaq” on September 06, 2019, also Nasdaq.com with their article: “Sirius XM (SIRI) Down 2.1% Since Last Earnings Report: Can It Rebound? – Nasdaq” published on August 29, 2019, Nasdaq.com published: “TRCO vs. SIRI: Which Stock Is the Better Value Option? – Nasdaq” on June 25, 2019. More interesting news about Sirius XM Holdings Inc. (NASDAQ:SIRI) were released by: Finance.Yahoo.com and their article: “Is Sirius XM Holdings Inc. (NASDAQ:SIRI) A Smart Choice For Dividend Investors? – Yahoo Finance” published on June 05, 2019 as well as Nasdaq.com‘s news article titled: “Apple Roundup: Tariffs, FAA, Russia, Music, App Store, Security – Nasdaq” with publication date: August 19, 2019.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.